Indoco Remedies is currently trading at Rs. 208.85, up by 6.15 points or 3.03% from its previous closing of Rs. 202.70 on the BSE.
The scrip opened at Rs. 213.90 and has touched a high and low of Rs. 218.70 and Rs. 207.45 respectively. So far 14071 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 238.00 on 26-Nov-2018 and a 52 week low of Rs. 150.25 on 08-Oct-2018.
Last one week high and low of the scrip stood at Rs. 218.70 and Rs. 182.30 respectively. The current market cap of the company is Rs. 1927.79 crore.
The promoters holding in the company stood at 58.83 % while Institutions and Non-Institutions held 16.21 % and 24.96 % respectively.
Indoco Remedies has received clearance from US Food and Drug Administration (USFDA) for its sterile manufacturing facility for Finished Dosages, located at Verna Industrial Area, Goa (Plant II). USFDA has signified that the site has come out of the ‘Warning Letter’ issued to the site in March 2017.
Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.
